Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Senti Biosciences, Inc. - Common Stock (NQ: SNTI ) 2.650 -0.060 (-2.21%) Streaming Delayed Price Updated: 3:53 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Senti Biosciences, Inc. - Common Stock < Previous 1 2 3 4 5 6 Next > SNTI Stock Earnings: Senti Biosciences Reported Results for Q2 2024 August 13, 2024 Senti Biosciences just reported results for the second quarter of 2024. Via InvestorPlace Senti Bio Announces Reverse Stock Split July 16, 2024 Shares expected to begin trading on split-adjusted basis on July 18, 2024 From Senti Biosciences, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 04, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 02, 2024 Pre-market stock movers are worth diving into this morning as we break down all of the biggest news moving shares on Tuesday! Via InvestorPlace SNTI Stock Earnings: Senti Biosciences Reported Results for Q1 2024 May 09, 2024 Senti Biosciences just reported results for the first quarter of 2024. Via InvestorPlace Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks July 02, 2024 Penny stocks are risky, but follow the money to find winners. Stocks with significant volume spikes may have what it takes for higher share prices. Via MarketBeat Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening? July 01, 2024 Senti Biosciences shares are trading higher by 102.6% during Monday's session. The company was awarded $8 million from the California Institute for Regenerative Medicines. Via Benzinga Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy July 01, 2024 $8M grant supports ongoing Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia From Senti Biosciences, Inc. Via GlobeNewswire Why Is Beyond Air (XAIR) Stock Down 22% Today? June 25, 2024 Beyond Air stock is down on Tuesday as investors in XAIR react to the company mixed earnings report for the first quarter of the year. Via InvestorPlace Why Is Faraday Future (FFIE) Stock Down 27% Today? June 25, 2024 Faraday Future stock is down on Tuesday after the troubled EV company announced plans for a reverse split of FFIE shares. Via InvestorPlace Why Is Senti Biosciences (SNTI) Stock Up 32% Today? June 25, 2024 Senti Biosciences stock is up on Tuesday with heavy pre-market trading of SNTI shares despite a lack of news from the company. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 25, 2024 Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning! Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session June 07, 2024 Via Benzinga Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia May 13, 2024 From Senti Biosciences, Inc. Via GlobeNewswire Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights May 09, 2024 From Senti Biosciences, Inc. Via GlobeNewswire Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML) April 30, 2024 From Senti Biosciences, Inc. Via GlobeNewswire SNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023 March 21, 2024 SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights March 21, 2024 From Senti Biosciences, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session January 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session January 22, 2024 Via Benzinga Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program January 05, 2024 From Senti Biosciences, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session December 25, 2023 Via Benzinga Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today? December 22, 2023 Senti Biosciences Inc (NASDAQ: SNTI) received FDA clearance for its Investigational New Drug (IND) application for SENTI-202, an off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cell... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Friday's Pre-Market Session December 22, 2023 Via Benzinga Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia December 22, 2023 From Senti Biosciences, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session December 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session December 12, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday December 12, 2023 Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading! Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session December 07, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 16, 2023 It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday! Via InvestorPlace < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.